Glenmark Pharma gets USFDA nod for ear drops

The company's current portfolio consists of 146 products authorised for distribution at the US marketplace and 54 abbreviated new drug applications (ANDAs) pending approval with the USFDA.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news